Secondary immunodeficiency related to kidney disease (SIDKD)—definition, unmet need, and mechanisms

S Steiger, J Rossaint, A Zarbock… - Journal of the American …, 2022 - journals.lww.com
Kidney disease is a known risk factor for poor outcomes of COVID-19 and many other
serious infections. Conversely, infection is the second most common cause of death in …

Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials

S Steiger, L Ehreiser, J Anders, HJ Anders - Frontiers in Immunology, 2022 - frontiersin.org
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that frequently
affects the kidneys, known as lupus nephritis (LN). Such patients are treated with …

COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients

D Gibertoni, C Reno, P Rucci, MP Fantini, A Buscaroli… - PloS one, 2021 - journals.plos.org
Many studies reported a higher risk of COVID-19 disease among patients on dialysis or with
kidney transplantation, and the poor outcome of COVID-19 in these patients. Patients in …

Prognostic role of anemia in COVID-19 patients: a meta-analysis

M Zuin, G Rigatelli, L Quadretti, L Fogato… - Infectious disease …, 2021 - mdpi.com
Introduction. The prevalence and prognostic implications of anemia in patients infected by
the SARS-CoV-2 remains unclear. We performed a systematic review and meta-analysis to …

The immune, inflammatory and hematological response in COVID-19 patients, according to the severity of the disease

F Trofin, EV Nastase, A Vâță, LS Iancu, C Luncă… - Microorganisms, 2023 - mdpi.com
Introduction: The aim of this study was to evaluate the immune and inflammatory responses
in COVID-19 patients by dosing specific IgM and IgG total antibodies and interleukin 6 …

Significant association between anemia and higher risk for COVID-19 mortality: A meta-analysis of adjusted effect estimates

Y Wang, L Nan, M Hu, R Zhang, Y Hao, Y Wang… - The American Journal of …, 2022 - Elsevier
Objective This study aimed to evaluate whether there was a significant relationship between
anemia and the risk for mortality among coronavirus disease 2019 (COVID-19) patients by a …

Specific risk factors for fatal outcome in critically ill COVID-19 patients: results from a European multicenter study

D Meintrup, S Borgmann, K Seidl, M Stecher… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: The aim of our study was to identify specific risk factors for fatal outcome in
critically ill COVID-19 patients.(2) Methods: Our data set consisted of 840 patients enclosed …

Clinical Presentation and Outcomes of Hospitalized Patients with Chronic Kidney Disease and COVID-19 Variant Omicron

X Wang, X Cao, S Liang, G Cai - Therapeutics and Clinical Risk …, 2024 - Taylor & Francis
Purpose To investigate the clinical characteristics of hospitalized patients with chronic
kidney disease (CKD) and novel coronavirus (SARS-CoV-2) infection and identify potential …

In vitro antimicrobial, semisynthesis and in silico studies of 1, 2-naphthoquinone derivatives

A Dessie, S Degu, A Abebe, D Bisrat - Journal of Molecular Structure, 2025 - Elsevier
Naphthoquinones have emerged as a potential class of compounds for treating microbial
infections. In this study, our aim was to synthesize 1, 2-naphthoquinones (1, 2 NQs) starting …

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis

M Jahn, J Korth, O Dorsch, OE Anastasiou, A Krawczyk… - Vaccines, 2022 - mdpi.com
This study analyzed binding and neutralizing antibody titers up to 6 months after standard
vaccination with BNT162b2 (two doses of 30 µg each) in SARS-CoV-2 naïve patients (n …